- Investing Ideas
- Global Pharmaceuticals & Biotech Healthy potentially undervalued
Global Pharmaceuticals & Biotech Healthy potentially undervalued
Results
188
Companies which are potentially undervalued and in an acceptable financial position.
188 companies
Tasly Pharmaceutical Group
Market Cap: CN¥21.0b
Engages in the research, development, production, and sale of pharmaceuticals in China.
600535
CN¥14.08
7D
0.6%
1Y
-11.2%
Pharma Mar
Market Cap: €1.4b
A biopharmaceutical company, focuses on the research, development, production, and commercialization of bio-active principles for the use in oncology in Spain, Germany, Ireland, France, Switzerland, rest of the European Union, the United States, and internationally.
PHM
€78.80
7D
-1.7%
1Y
-2.7%
High Tide
Market Cap: CA$276.8m
Engages in the cannabis retail business in Canada, the United States, and internationally.
HITI
CA$3.12
7D
-4.0%
1Y
-3.4%
Zhejiang Jiuzhou Pharmaceutical
Market Cap: CN¥13.0b
Operates as contract development and manufacturing organization (CDMO) company in China and internationally.
603456
CN¥14.77
7D
0.9%
1Y
-10.2%
Innovent Biologics
Market Cap: HK$155.9b
A biopharmaceutical company, engages in the research and development of antibody and protein medicine products in the People’s Republic of China, the United States, Europe, and internationally.
1801
HK$89.70
7D
2.2%
1Y
11.4%
3SBio
Market Cap: HK$45.2b
An investment holding company, engages in the development, production, marketing, and sale of biopharmaceutical products in the People’s Republic of China, the United States, and internationally.
1530
HK$18.07
7D
-7.6%
1Y
-28.2%
Arcutis Biotherapeutics
Market Cap: US$3.6b
A biopharmaceutical company, focuses on developing and commercializing treatments for dermatological diseases.
ARQT
US$27.74
7D
7.5%
1Y
84.8%
Hypera
Market Cap: R$14.9b
Operates as a pharmaceutical company in Brazil.
HYPE3
R$21.11
7D
0.6%
1Y
-21.8%
Regeneron Pharmaceuticals
Market Cap: US$68.0b
Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines to treat various diseases worldwide.
REGN
US$664.52
7D
1.6%
1Y
17.0%
Sanofi
Market Cap: €91.5b
Engages in the research, development, manufacture, and marketing of therapeutic solutions.
SAN
€76.23
7D
0.6%
1Y
-8.2%
CorMedix
Market Cap: US$680.2m
A biopharmaceutical company, focuses on developing and commercializing therapeutic products for life-threatening diseases and conditions in the United States.
CRMD
US$8.40
7D
-4.0%
1Y
-25.1%
Yunnan Baiyao GroupLtd
Market Cap: CN¥87.1b
Engages in the sale of pharmaceuticals, medicinal materials, health and daily chemical products in China.
000538
CN¥48.82
7D
-0.08%
1Y
-12.9%
Hugel
Market Cap: ₩2.6t
Develops and manufactures biopharmaceuticals in South Korea and internationally.
A145020
₩240,500.00
7D
-5.7%
1Y
-30.7%
Dong-A Socio Holdings
Market Cap: ₩549.5b
Engages in the pharmaceutical business in South Korea.
A000640
₩82,900.00
7D
0.1%
1Y
-29.7%
Shanghai Fosun Pharmaceutical (Group)
Market Cap: CN¥56.9b
Shanghai Fosun Pharmaceutical (Group) Co., Ltd.
600196
CN¥23.45
7D
0.7%
1Y
-8.4%
Elanco Animal Health
Market Cap: US$12.3b
An animal health company, innovates, develops, manufactures, and markets products for pets and farm animals worldwide.
ELAN
US$24.82
7D
-0.7%
1Y
66.6%
Vetoquinol
Market Cap: €825.2m
A veterinary pharmaceutical company, designs, develops, and sells veterinary drugs and non-medicinal products for cattle, pigs, dogs, and cats in Europe, the Americas, and the Asia Pacific region.
VETO
€71.00
7D
0.3%
1Y
-9.0%
Supernus Pharmaceuticals
Market Cap: US$2.8b
A biopharmaceutical company, engages in the development and commercialization of products for the treatment of central nervous system (CNS) diseases in the United States.
SUPN
US$48.46
7D
0.9%
1Y
46.3%
Dong-E-E-Jiao
Market Cap: CN¥29.9b
Engages in the research, development, production, and sale of donkey-hide gelatin and related products in China and internationally.
000423
CN¥46.79
7D
-0.6%
1Y
-7.4%
Collegium Pharmaceutical
Market Cap: US$1.2b
A specialty pharmaceutical company, engages in the development and commercialization of medicines for pain management.
COLL
US$35.23
7D
-4.9%
1Y
8.3%
Virbac
Market Cap: €2.7b
Manufactures and sells a range of products and services for companion and farm animals in Europe, North America, Latin America, East Asia, India, Africa, the Middle East, the United States, Brazil, and the Pacific.
VIRP
€320.50
7D
-3.5%
1Y
-6.0%
Bavarian Nordic
Market Cap: DKK 14.0b
Develops, manufactures, and supplies life-saving vaccines.
BAVA
DKK 183.50
7D
-3.7%
1Y
1.5%
Diaceutics
Market Cap: UK£120.7m
A diagnostic commercialization company, provides data, data analytics, and implementation services for pharma and biotech companies.
DXRX
UK£1.43
7D
-2.4%
1Y
19.7%
Ardelyx
Market Cap: US$1.3b
Ardelyx, Inc. discovers, develops, and commercializes medicines to treat unmet medical needs in the United States and internationally.
ARDX
US$5.28
7D
0.2%
1Y
17.6%
Amoy Diagnostics
Market Cap: CN¥6.7b
Engages in research and development, production, sale, and supporting services of tumor precision medical diagnostic products in China and internationally.
300685
CN¥17.42
7D
-3.2%
1Y
-23.7%
Duopharma Biotech Berhad
Market Cap: RM 1.2b
Researches, develops, manufactures, markets, sells, imports, and distributes pharmaceutical products and medicines in Malaysia and internationally.
DPHARMA
RM 1.24
7D
0%
1Y
-10.1%
Dong-A ST
Market Cap: ₩350.4b
Develops, manufactures, and markets pharmaceutical products in South Korea and internationally.
A170900
₩36,350.00
7D
3.1%
1Y
-24.1%
Decibel Cannabis
Market Cap: CA$63.5m
An integrated cannabis company, engages in the cannabis cultivation, processing, and sale of cannabis flower products in Canada.
DB
CA$0.11
7D
-4.3%
1Y
29.4%
Tarsus Pharmaceuticals
Market Cap: US$2.8b
A commercial stage biopharmaceutical company, focuses on the development and commercialization of therapeutic candidates for eye care in the United States.
TARS
US$58.14
7D
-11.2%
1Y
48.4%
Fennec Pharmaceuticals
Market Cap: US$358.1m
Operates as a commercial stage biopharmaceutical company in the United States.
FENC
US$10.49
7D
-2.0%
1Y
19.5%
Journey Medical
Market Cap: US$192.7m
A commercial-stage pharmaceutical company that focuses on the development and commercialization of pharmaceutical products for the treatment of dermatological conditions in the United States.
DERM
US$6.91
7D
-2.5%
1Y
-3.4%
WuXi AppTec
Market Cap: CN¥372.3b
An investment holding company, provides research and manufacturing services to discover, develop, and manufacture spectrum for small molecule drugs in the People’s Republic of China, the United States, Europe, and internationally.
603259
CN¥123.30
7D
-0.7%
1Y
59.8%
Daewoong Pharmaceutical
Market Cap: ₩1.5t
Develops, manufactures and commercializes pharmaceutical products in South Korea and internationally.
A069620
₩131,900.00
7D
-0.5%
1Y
-18.3%
China Resources Pharmaceutical Group
Market Cap: HK$28.3b
An investment holding company, engages in the manufacture, distribution, and retail of pharmaceutical and other healthcare products in Mainland China and internationally.
3320
HK$4.50
7D
0%
1Y
-15.1%
United Laboratories International Holdings
Market Cap: HK$18.0b
An investment holding company, engages in the research and development, manufacture, distribution, and sale of pharmaceutical products.
3933
HK$9.13
7D
-2.5%
1Y
-35.8%
Exagen
Market Cap: US$111.6m
Designs, develops, and commercializes various testing products under the AVISE brand in the United States.
XGN
US$4.45
7D
-2.0%
1Y
-36.3%